AVIGENICS LIMITED

Company Registration Number:
13211134 (England and Wales)

Unaudited statutory accounts for the year ended 29 February 2024

Period of accounts

Start date: 01 March 2023

End date: 29 February 2024

AVIGENICS LIMITED

Contents of the Financial Statements

for the Period Ended 29 February 2024

Company Information - 3
Report of the Directors - 4
Balance sheet - 5
Additional notes - 7
Balance sheet notes - 10

AVIGENICS LIMITED

Company Information

for the Period Ended 29 February 2024




Director: Venkat Raghavan Madabushi
Secretary: Venkat Raghavan Madabushi
Registered office: 134
Imperial Drive
North Harrow
GBR
HA2 7HT
Company Registration Number: 13211134 (England and Wales)

AVIGENICS LIMITED

Directors' Report Period Ended 29 February 2024

The directors present their report with the financial statements of the company for the period ended 29 February 2024

Principal Activities

Birds DNA Technical and testing Analysis

Directors

The director(s) shown below were appointed to the company during the period
Venkat Raghavan Madabushi
01 March 2023

Secretary
Venkat Raghavan Madabushi

This report was approved by the board of directors on 15 October 2024
And Signed On Behalf Of The Board By:

Name: Venkat Raghavan Madabushi
Status: Director

AVIGENICS LIMITED

Balance sheet

As at 29 February 2024


Notes

2024
£

2023
£
Fixed assets
Total fixed assets: - -
Current assets
Cash at bank and in hand: 5,302 3,633
Total current assets: 5,302 3,633
Creditors: amounts falling due within one year: 4 ( 1,092 ) ( 940 )
Net current assets (liabilities): 4,210 2,693
Total assets less current liabilities: 4,210 2,693
Total net assets (liabilities): 4,210 2,693

The notes form part of these financial statements

AVIGENICS LIMITED

Balance sheet continued

As at 29 February 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 4,209 2,692
Shareholders funds: 4,210 2,693

For the year ending 29 February 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 15 October 2024
And Signed On Behalf Of The Board By:

Name: Venkat Raghavan Madabushi
Status: Director

The notes form part of these financial statements

AVIGENICS LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

AVIGENICS LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 2 1

AVIGENICS LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

  • 3. Off balance sheet disclosure

    No

AVIGENICS LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

4.Creditors: amounts falling due within one year note


2024
£

2023
£
Bank loans and overdrafts 1,092 114
Trade creditors 826
Total 1,092 940

Bank credit card will clear falling with in one year